ALA went up about 50% ( 4c-6c ) when they did a similar webinar last week. ALA just got 1 pre-clinical asset, currently preparing pre-clinical combo with IMU. CHM got 3 asset platforms, 2 already in ph 1 clinical and soon the third in ph 1 as well.
CHM's MC still below ALA - correct, an absolute bargain.
GLTA
Ann: CHM to host CAR T Cell Therapies Educational Webinar, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $16.64M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 1.9¢ | $31.47K | 1.541M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1200682 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 12227 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| CHM (ASX) Chart |